Clinical trial

A 3-fold Crossover Bioequivalence Study Between Glucobay Orally Disintegrating Tablet (ODT) and Glucobay Standard Tablet

NCT01388153

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-06-01

PhasePHASE1

Study timeline

Study start (unknown)2011-06-01Date precision: month

Registry last updated2013-08-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Acarbose (Glucobay ODT, BAYG5421)DRUG

Acarbose (Glucobay, BAYG5421)DRUG

Sponsors & collaborators

Bayerlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01388153 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.